A New Era in Cardiovascular Treatment Innovation.
Orchestra Biomed has unveiled a revolutionary breakthrough in the treatment of cardiovascular disease....
FDA approval Vutrisiran ATTR-CM treatment for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults
This is a significant milestone...